Drug‐Induced Metabolic Syndrome
- 1 February 2006
- journal article
- review article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 8 (2), 114-119
- https://doi.org/10.1111/j.1524-6175.2006.04751.x
Abstract
The metabolic syndrome is a cluster of risk factors associated with an increased risk for cardiovascular disease and type 2 diabetes. Based on data from 1988 to 1994, it is estimated that 24% of adults in the United States meet the criteria for diagnosis of the metabolic syndrome. The use of certain medications may increase the risk of the metabolic syndrome by either promoting weight gain or altering lipid or glucose metabolism. Health providers should recognize and understand the risk associated with certain medications and appropriately monitor for changes related to the metabolic syndrome. Careful attention to drug choices should be paid in patients who are overweight or have other risk factors for diabetes or cardiovascular disease.Keywords
This publication has 40 references indexed in Scilit:
- Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetesThe American Journal of Cardiology, 2005
- Adverse Prognostic Significance of New Diabetes in Treated Hypertensive SubjectsHypertension, 2004
- Acquired and Inherited LipodystrophiesThe New England Journal of Medicine, 2004
- Impact of adjunctive thiazolidinedione therapy on blood lipid levels and glycemic control in patients with type 2 diabetesCurrent Medical Research and Opinion, 2004
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Jama-Journal Of The American Medical Association, 2002
- Obesity Hypertension in ChildrenHypertension, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)Jama-Journal Of The American Medical Association, 2001
- Hypothesis: β-Adrenergic Receptor Blockers and Weight GainHypertension, 2001
- Drug-Induced Lipid ChangesDrug Safety, 2001